Ingevity Corp NGVT
We take great care to ensure that the data presented and summarized in this overview for Ingevity Corp is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding NGVT
View all-
Black Rock Inc. New York, NY5.67MShares$267 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.21MShares$198 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA2.12MShares$100 Million0.01% of portfolio
-
State Street Corp Boston, MA1.55MShares$72.9 Million0.0% of portfolio
-
Thrivent Financial For Lutherans Minneapolis, MN1.38MShares$65.2 Million0.1% of portfolio
-
Segall Bryant & Hamill, LLC Chicago, IL1.19MShares$55.8 Million0.65% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.08MShares$50.9 Million0.02% of portfolio
-
American Century Companies Inc Kansas City, MO1.06MShares$49.9 Million0.02% of portfolio
-
Victory Capital Management Inc990KShares$46.6 Million0.04% of portfolio
-
Royce & Associates LP934KShares$44 Million0.35% of portfolio
Latest Institutional Activity in NGVT
Top Purchases
Top Sells
About NGVT
Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, motorcycles, trucks, and boats. This segment also produces other activated carbon products for use in various applications, including food, water, beverage, and chemical purification. The Performance Chemicals segment comprises of pavement technologies, industrial specialties, and engineered polymers. It manufactures products derived from crude tall oil and lignin extracted from the kraft pulping process, as well as caprolactone monomers and derivatives derived from cyclohexanone and hydrogen peroxide. This segment's products are used in various applications comprising warm mix paving, pavement preservation, pavement reconstruction and recycling, oil well service additives, oil production, and downstream applications; and adhesives, agrochemical dispersants, lubricants, printing inks, industrial intermediates and oilfield, coatings, resins, elastomers, bioplastics, and medical devices. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.
Insider Transactions at NGVT
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 17
2024
|
J Kevin Willis |
BUY
Grant, award, or other acquisition
|
Direct |
1,816
+36.11%
|
$38,136
$21.7 P/Share
|
Oct 02
2024
|
Luis M Fernandez Moreno Interim President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
26,696
+35.25%
|
-
|
Aug 09
2024
|
Phillip John Platt SVP, Finance |
BUY
Grant, award, or other acquisition
|
Direct |
11,233
+28.88%
|
-
|
Jul 05
2024
|
Ryan C. Fisher SVP, Gen. Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
1,163
+9.48%
|
-
|
Jul 01
2024
|
Richard Allen White Jr SVP and Pres, Perf Chemicals |
SELL
Payment of exercise price or tax liability
|
Direct |
191
-1.3%
|
$8,022
$42.18 P/Share
|
May 03
2024
|
Ryan C. Fisher SVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
756
-7.06%
|
$40,068
$53.56 P/Share
|
Apr 24
2024
|
Jean S Blackwell |
BUY
Grant, award, or other acquisition
|
Direct |
2,800
+38.65%
|
-
|
Apr 24
2024
|
Diane H. Gulyas |
BUY
Grant, award, or other acquisition
|
Direct |
2,800
+24.08%
|
-
|
Apr 24
2024
|
Luis M Fernandez Moreno Interim President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
2,800
+11.13%
|
-
|
Apr 24
2024
|
Frederick J Lynch |
BUY
Grant, award, or other acquisition
|
Direct |
2,800
+11.15%
|
-
|
Apr 24
2024
|
Bruce D. Hoechner |
BUY
Grant, award, or other acquisition
|
Direct |
2,800
+36.98%
|
-
|
Apr 24
2024
|
Karen G Narwold |
BUY
Grant, award, or other acquisition
|
Direct |
2,800
+17.79%
|
-
|
Apr 24
2024
|
Benjamin G. Wright |
BUY
Grant, award, or other acquisition
|
Direct |
2,800
+31.87%
|
-
|
Apr 24
2024
|
Daniel F Sansone |
BUY
Grant, award, or other acquisition
|
Direct |
2,800
+17.92%
|
-
|
Apr 19
2024
|
Mary Dean Hall EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,227
-3.26%
|
$97,988
$44.44 P/Share
|
Feb 28
2024
|
Steven Paul Hulme SVP and Pres, APT |
BUY
Grant, award, or other acquisition
|
Direct |
2,431
+26.25%
|
-
|
Feb 28
2024
|
Steven Paul Hulme SVP and Pres, APT |
SELL
Payment of exercise price or tax liability
|
Direct |
247
-8.75%
|
$11,115
$45.27 P/Share
|
Feb 28
2024
|
Phillip John Platt SVP, Finance |
BUY
Grant, award, or other acquisition
|
Direct |
3,591
+9.89%
|
-
|
Feb 28
2024
|
Phillip John Platt SVP, Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
339
-1.29%
|
$15,255
$45.27 P/Share
|
Feb 28
2024
|
Christine Stunyo SVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
351
-3.87%
|
$15,795
$45.27 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 180K shares |
---|
Payment of exercise price or tax liability | 26.4K shares |
---|